252 related articles for article (PubMed ID: 33958886)
1. Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.
Zhang H; Tang K; Wang Y; Fang R; Sun Q
Clin Cosmet Investig Dermatol; 2021; 14():407-417. PubMed ID: 33958886
[TBL] [Abstract][Full Text] [Related]
2. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
He G; Yang Q; Wu J; Huang Y; Zheng H; Cheng H
J Cosmet Dermatol; 2024 Jan; 23(1):44-61. PubMed ID: 37605478
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.
Park KY; Kwon HJ; Kim JM; Jeong GJ; Kim BJ; Seo SJ; Kim MN
Ann Dermatol; 2018 Dec; 30(6):688-693. PubMed ID: 33911508
[TBL] [Abstract][Full Text] [Related]
4. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Logger JGM; Olydam JI; Driessen RJB
J Am Acad Dermatol; 2020 Oct; 83(4):1088-1097. PubMed ID: 32360760
[TBL] [Abstract][Full Text] [Related]
5. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea.
Yang R; Liu C; Liu W; Luo J; Cheng S; Mu X
Dermatol Ther (Heidelb); 2022 Oct; 12(10):2285-2294. PubMed ID: 35925473
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis.
Xiao W; Chen M; Wang B; Huang Y; Zhao Z; Deng Z; Xie H; Li J; Tang Y
Front Pharmacol; 2023; 14():1169916. PubMed ID: 37251342
[No Abstract] [Full Text] [Related]
8. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
Al-Niaimi F; Glagoleva E; Araviiskaia E
Dermatol Ther; 2020 Nov; 33(6):e13976. PubMed ID: 32633449
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
Luque A; Rojas AP; Ortiz-Florez A; Perez-Bernal J
J Clin Aesthet Dermatol; 2021 Mar; 14(3):42-45. PubMed ID: 33841616
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Safety of Botulinum Toxin A for the Treatment of Rosacea: A Systematic Review.
Alsaati AA; Alsaadoun D; Kinkar LI; Alkhamis RS; Ahmed WA; Almathami AH
Cureus; 2023 Dec; 15(12):e51304. PubMed ID: 38288198
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injection for chronic pelvic pain: A systematic review.
Luo FY; Nasr-Esfahani M; Jarrell J; Robert M
Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1595-1602. PubMed ID: 32597494
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Low-Dose Isotretinoin in the Treatment of Rosacea: A Systematic Review and Meta-Analysis.
Assiri A; Hobani AH; AlKaabi HA; Mojiri ME; Daghriri SA; Suwaid OA; Alameer MI; Akkam MM; Alamir MA; Albarr AA; Alshaikh MR; Sumayli AM; Akkam FM; Hakami HA
Cureus; 2024 Mar; 16(3):e57085. PubMed ID: 38681262
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin as a double-edged sword in alopecia: A systematic review.
Wang Y; Zhang H; Zheng Q; Tang K; Fang R; Sun Q
J Cosmet Dermatol; 2020 Oct; 19(10):2560-2565. PubMed ID: 32745302
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatments for rosacea.
Layton AM
Clin Dermatol; 2017; 35(2):207-212. PubMed ID: 28274361
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in treating Hailey-Hailey disease: A systematic review.
Zhang H; Tang K; Wang Y; Fang R; Sun Q
J Cosmet Dermatol; 2021 May; 20(5):1396-1402. PubMed ID: 33533135
[TBL] [Abstract][Full Text] [Related]
16. Emerging Medical Therapies in Rosacea: A Narrative Review.
Choe J; Barbieri JS
Dermatol Ther (Heidelb); 2023 Dec; 13(12):2933-2949. PubMed ID: 37824060
[TBL] [Abstract][Full Text] [Related]
17. Topical calcineurin inhibitors as a double-edged sword in rosacea: A systematic review.
Zhang H; Yang L; Wang Y; Zhang D; Tang K; Fang R; Sun Q
J Cosmet Dermatol; 2022 Apr; 21(4):1695-1704. PubMed ID: 34192412
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Botulinum Toxin Type A in Treatment of Restless Legs Syndrome: A Systematic Review and Meta-Analysis.
Su YC; Guo YH; Liao CL; Lin YC
Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
